Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase EARLY_PHASE1 1

Status

Completed 2Unknown 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 5INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5CNS 1

Conditions

Breast Neoplasms 5Brain Neoplasms 2Triple Negative Breast Neoplasms 1Solid Tumor, Adult 1Meningeal Neoplasms 1Breast Cancer Metastatic 1

Interventions

Cyclophosphamide 361Trastuzumab 352Paclitaxel 304Docetaxel 272Letrozole 221Capecitabine 221Carboplatin 185Doxorubicin 181Tamoxifen 157Radiotherapy 154Epirubicin 145Fulvestrant 143Anastrozole 139Surveys and Questionnaires 132Exercise 128pertuzumab 113Vinorelbine 110Blood Specimen Collection 109exemestane 106palbociclib 104Bevacizumab 104pembrolizumab 98Magnetic Resonance Spectroscopy 97Albumin-Bound Paclitaxel 87Gemcitabine 84Drug Therapy 83Lapatinib 78130-nm albumin-bound paclitaxel 72Neoadjuvant Therapy 71Cisplatin 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Breast Neoplasms × patritumab deruxtecan × Clear all
NCT04699630 2026-05-22

A Study of U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast Cancer

SCRI Development Innovations, LLC

Phase 2 Completed
121 enrolled 15 charts
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05865990 2026-05-04

TUXEDO-3

MedSIR

Phase 2 Completed
63 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms, Meningeal Neoplasms

NCT04965766 2025-12-23

ICARUS BREAST

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Recruiting
139 enrolled
Breast

Breast Neoplasms

NCT05569811 2023-09-21

VALENTINE

SOLTI Breast Cancer Research Group

Phase 2 Active not recruiting
120 enrolled
Breast

Breast Neoplasms

NCT04610528 2023-06-23

TOT-HER3

SOLTI Breast Cancer Research Group

Phase EARLY_PHASE1 Unknown
80 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡